Grand Hyatt New York

News & Analysis

grand hyatt new york and life science - All News and Analysis

• Antigenics to Present at UBS Global Life Sciences Conference

  - 2007-09-20

  NEW YORK -- Antigenics Inc. (NASDAQ: AGEN) today announced that Shalini Sharp, the company's chief financial officer and vice president, will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York at 2:00 p.m. ET on Thursday, September 27.

  Tags: life science, UBS AG

• Acceleron Pharma to Present at the UBS 2007 Global Life Sciences Conference

  - 2007-09-20

  CAMBRIDGE, Mass. -- Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a corporate presentation at the UBS 2007 Global Life Sciences Conference on Thursday September 27,...

  Tags: life science, UBS AG

• ACADIA Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference

  - 2007-09-19

  SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the 2007 UBS Global Life Sciences Conference on Wednesday, September 26, 2007, at 2:00 p.m....

  Tags: life science, UBS AG

• ZOLL Medical Corporation to Speak at the UBS Global Life Sciences Conference

  - 2007-09-19

  CHELMSFORD, Mass. -- ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that A. Ernest Whiton, its Chief Financial Officer, will speak at 4:00 p.m. on Monday, September 24, 2007 in New York City, at the UBS Global Life Sciences Conference being held...

  Tags: life science, UBS AG

• Medical Action Industries To Present in the 2007 UBS Global Life Sciences Conference

  - 2007-09-07

  HAUPPAUGE, N.Y. -- Medical Action Industries Inc. (NASDAQ/MDCI), a leading supplier of medical and surgical disposable products, today announced that it will be presenting at the 2007 UBS Global Life Sciences Conference to be held on September 24-27, 2007 at the Grand Hyatt New York. The Medical Action presentation will...

  Tags: UBS AG, life science

• Javelin Pharmaceuticals To Present Recent Clinical Results of Its Lead Product Dyloject™ at UBS Global Life Sciences Conference

  - 2006-09-26

  BOSTON -- Javelin Pharmaceuticals, Inc. (Amex: JAV) announced today plans to present at the UBS Global Life Sciences Conference on Thursday, September 28, 2006 at 1:30 p.m. EDT in Ballroom D at the Grand Hyatt, New York City. Dr. Daniel Carr, M.D., CEO and CMO of Javelin will present a...

  Tags: life science, UBS AG

• DUSA Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference

  - 2005-09-21

  WILMINGTON, Mass. -- DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that Dr. Geoffrey Shulman, the Company's Chairman & CEO and Mr. Robert Doman, the President & COO will be presenting on Monday, September 26th at 3:30 p.m. Eastern at the UBS Global Life Sciences Conference taking...

  Tags: life science, UBS AG

• DUSA Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference.

  - 2005-09-21

  WILMINGTON, MASSACHUSETTS, Sep 21, 2005 CCNMatthews via COMTEX -- DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that Dr. Geoffrey Shulman, the Company's Chairman & CEO and Mr. Robert Doman, the President & COO will be present WILMINGTON, MASSACHUSETTS, Sep 21, 2005 CCNMatthews via COMTEX -- ...

  Tags: life science, UBS AG

• CVBT Will Present at the UBS Global Life Sciences Conference

  - 2005-09-20

  HENDERSON, Nev. -- CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) announced today that Mr. Daniel C. Montano, Chairman of the Board, President, and CEO of CardioVascular BioTherapeutics, Inc. CVBT, has been invited to present CVBT's Story at the UBS Global Life Sciences Conference scheduled for Monday, September 26 - Thursday, September 29, 2005...

  Tags: life science, UBS AG

• DUSA Pharmaceuticals, Inc. To Present At UBS Global Life Sciences Conference

  - 2004-09-23

  WILMINGTON, Mass. -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) announced today that Dr. Geoffrey Shulman, the Company's President & CEO, will be presenting on Monday, September 27th at 4:30 p.m. Eastern at the UBS Global Life Sciences Conference taking place at The Grand Hyatt New York.

  Tags: life science, UBS AG